(October 16, 2018, 1:58 PM EDT) -- BOSTON — The First Circuit U.S. Court of Appeals on Oct. 15 reversed certification of a class that alleges that former drug maker Warner Chilcott violated state consumer laws by withdrawing the drug Asacol before its patent expired and introducing a similar drug with patent protection and blocking the introduction of cheaper Asacol generic competitors (In Re: Asacol Antitrust Litigation, United Food and Commercial Workers Unions, et al. v. Warner Chilcott Limited, et al., No. 18-1065, 1st Cir., 2018 U.S. App. LEXIS 28920)....